Literature DB >> 24921459

Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.

Yutao Guo1, Yingchun Tian2, Hao Wang1, Quanjin Si1, Yutang Wang1, Gregory Y H Lip3.   

Abstract

BACKGROUND: Much of the epidemiology of atrial fibrillation (AF) is based on data from Western populations. Despite the huge population of Asia, data on the clinical epidemiology of AF in Asian countries are limited. The current study aimed to investigate the prevalence and incidence of newly diagnosed (ie, incident) AF, as well as lifetime risk, in China and to determine the clinical risk factors contributing to its development.
METHODS: Using a medical insurance database involving > 10 million individuals for the years 2001 to 2012 in the southwest of China, trends in incident AF were calculated using Kaplan-Meier analysis and Cox regression. The usefulness of the CHADS2 (congestive heart failure, hypertension, age, diabetes, stroke [doubled]) and CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 [doubled], diabetes, stroke [doubled], vascular disease, age 65-74, and sex category [female]) scores was tested in predicting the occurrence of incident AF.
RESULTS: A total of 471,446 individuals (aged ≥ 20 years) were studied, with 1,924,975 person-years of experience. We identified 921 patients with incident AF (62% male; mean age, 62 years). The prevalence of incident AF in subjects aged ≥ 20 years was 0.2 per 100 people, with an incidence of AF of 0.05 per 100 person-years overall. Over an 11-year period, the prevalence of AF increased 20-fold, whereas AF-related stroke increased 13-fold. The lifetime risk of AF was approximately one in five among Chinese adults, and it increased with advancing age. The CHA2DS2-VASc score was superior to the CHADS2 score in predicting the risk of incident AF in our Chinese population (DeLong test, Z = 6.621, P < .001).
CONCLUSIONS: The AF burden, as well as the risk of AF-related stroke, has increased significantly over the past 11 years in the southwest of China. The public health burden of AF and its complications are greatest in the very elderly, with major implications for health-care systems given the global burden of this common arrhythmia.

Entities:  

Mesh:

Year:  2015        PMID: 24921459     DOI: 10.1378/chest.14-0321

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  74 in total

Review 1.  Improved treatment capacity and quality of care: the effectiveness of the stroke prevention and treatment system in Shanghai, China from 2012-2017.

Authors:  Bifan Zhu; Duo Chen; Chunlin Jin; Peipei Song; Fen Li
Journal:  Glob Health Med       Date:  2020-02-29

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 3.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 4.  Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.

Authors:  Robert J Mentz; Lothar Roessig; Barry H Greenberg; Naoki Sato; Kaori Shinagawa; Daniel Yeo; Bernard W K Kwok; Eugenio B Reyes; Henry Krum; Burkert Pieske; Stephen J Greene; Andrew P Ambrosy; Jacob P Kelly; Faiez Zannad; Bertram Pitt; Carolyn S P Lam
Journal:  JACC Heart Fail       Date:  2016-06       Impact factor: 12.035

5.  A prospective study investigating the causes of warfarin under-utilization in Chinese patients.

Authors:  Shujuan Zhao; Hongwei Zhao; Xianpei Wang; Chuanyu Gao; Yuhua Qin; Haixia Cai; Boya Chen; Jingjing Cao
Journal:  Int J Clin Pharm       Date:  2016-08-03

6.  Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.

Authors:  Xintao Li; Lianjun Gao; Zhao Wang; Bo Guan; Xumin Guan; Binhao Wang; Xu Han; Xianjie Xiao; Khalid Bin Waleed; Clarance Chandran; Shouling Wu; Yunlong Xia
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

7.  Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.

Authors:  Yu-Yi Chen; Yong-Hua Zhang; Xin Chen; Wei-Ping Huang; Bei Xu; Xi Su; Yan-Hong Chen
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-18       Impact factor: 2.357

8.  Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region.

Authors:  Edgar Tay; Biswajit Paul; Jason Sharp; Dennis Wang; Angus Shing Fung Chui; Prakash Kumar Hazra; Teguh Santoso; Bert Albers; Hans-Christoph Diener; Thorsten Lewalter; Andrew Wong
Journal:  J Interv Card Electrophysiol       Date:  2020-06-26       Impact factor: 1.900

9.  Incidence of atrial fibrillation and its risk prediction model based on a prospective urban Han Chinese cohort.

Authors:  L Ding; J Li; C Wang; X Li; Q Su; G Zhang; F Xue
Journal:  J Hum Hypertens       Date:  2017-03-30       Impact factor: 3.012

10.  Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.

Authors:  Amir Y Shaikh; Nada Esa; William Martin-Doyle; Menhel Kinno; Iryna Nieto; Kevin C Floyd; Clifford Browning; Cynthia Ennis; J Kevin Donahue; Lawrence S Rosenthal; David D McManus
Journal:  Crit Pathw Cardiol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.